.png)
The Stride Dystonia clinical research study will test a new investigational drug known as VIM0423 to see if it is effective in reducing the severity of dystonia symptoms.
Interested potential participants may be able to join the study if the following criteria are met:
Aged 18-65 years old
Confirmed diagnosis of dystonia that is not caused by a separate neurological disorder
More than one body region is affected
Other study requirements will apply. Speak to a study doctor to learn more.
Participation in the Stride Dystonia study lasts about 32 weeks. Participants will be evaluated remotely for some study visits to lighten the burden of travel.
Study participants can expect the following:
1
1
A study doctor will assist in going over the Informed Consent Form (ICF) which contains important study information including the goals, duration, benefits, risks, tests and procedures.
2
2
Receive relevant study health assessments to confirm if you or your loved one qualifies for the study
3
3
The study drug, VIM0423, will be taken by mouth at home each day. How much is taken will increase weekly at the study doctor’s discretion until the goal dose is reached. Then, the dose will remain the same for the remainder of the treatment period.
4
4
During this period, the daily dose level of VIM0423 will be gradually reduced.
5
5
Participants will receive final study health assessments to evaluate progress and tolerability.
Participation in a clinical study is voluntary. You can ask any questions you have and may leave the study at any time, for any reason.
Take the pre-screener to see if you may qualify!
Take the Pre-ScreenerAnswer a few questions to see if you or your loved one may qualify!
Take the Pre-ScreenerVIM0423 is an investigational study drug being studied in individuals diagnosed with dystonia. For the Stride Dystonia study, the drug will be taken as two separate tablets, once each day.
In previous clinical studies, the safety of the investigational drug was assessed in healthy adult volunteers and a small number of participants with dystonia.
The Stride Dystonia study is placebo-controlled, meaning some participants will receive a tablet that does not contain the study drug. During the first study visit after the study doctor has determined you are eligible, participants will be randomly selected to receive study drug or placebo in a 50/50 fashion.
Investigational means the study medication is not approved by regulatory authorities like the US Food and Drug Administration (FDA), and it can only be used in clinical research studies like the Stride Dystonia study.
Here are some common questions and answers about study participation.
Clinical research studies, or trials, help scientists and doctors explore whether a medical procedure, device, or medication is safe and effective for people. Before any medication can be approved and made available to the public, it must go through several phases of clinical research.
All medicine that is prescribed by doctors was previously tested in clinical studies. In order to know if this investigational drug can help patients with dystonia, doctors must conduct clinical studies. By participating in the study, you are helping doctors to better understand the disease and this investigational drug.
Before enrolling in a clinical trial, you must sign an Informed Consent Form (ICF). The ICF contains information about the study, including study goals, how long the study will last, benefits and risks, and the tests and procedures you will receive.
Study participation usually involves visiting a clinic regularly, taking or receiving an investigational medicine, and having assessments to monitor your health. You can still see your regular doctor, but you should let them know that you are participating in a study.
Participation in a clinical research study is your choice, and you may stop at any time.
If you have additional questions about participating in a clinical research study, contact a study clinic near you.
Use the filters, map, and listing to find the study clinic closest to you. Contact the study clinic to learn more.